Allscripts Introduces New App Expo to Showcase a Broader Range of Integrated Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced today that its Application Store has been relaunched as the Allscripts App Expo The rebrand will ensure Allscripts clients have an engaging way to identify all applications that have been built and certified through the Allscripts Developer Program (ADP) using Allscripts proprietary and FHIR APIs, in addition to select third party solutions sold by Allscripts. Previously, only certain partner applications were searchable and featured on the company’s Application Store. With this expansion, Allscripts will provide the opportunity for all active developers with a certified solution to showcase their solutions online via the App Expo.

Allscripts, one of the world's largest Health IT companies, first exposed APIs for third party connectivity in 2007 and launched a full developer program to support interoperability with Allscripts solutions and the industry's first online application store in 2010. The company's developer program enables developers to connect with multiple Allscripts electronic health records (EHR) and practice management solutions. Allscripts supports integration with on-premise, data-center-hosted and cloud-hosted environments across all specialties and for all sizes of physician offices and hospital organizations. Today there are hundreds of certified apps and devices available for Allscripts clients to choose from, with new certified solutions frequently added to the site.

"Over the past few years, we have seen an unprecedented increase in funding for health technology start-ups, with more organizations than ever looking to connect with Allscripts solutions via FHIR, our proprietary APIs and the other connectivity options we support through our Developer Program. Our program has continued to grow and expand to support this activity and foster innovation in our industry," said Tina Joros, Vice President and General Manager of Allscripts. "The new App Expo is just the latest step toward making it easier for our clients to find solutions that will continue to help them improve their technology ecosystem and accomplish their practice and health system goals."

On March 8 at 10 a.m. ET, Tina Joros will participate in a panel discussion during ViVE 2022 in Miami, FL, titled "Setting the Future on FHIR or Setting FHIR on Fire." The panelists will discuss the continuum of data-sharing in healthcare, the ever-evolving world of interoperability and more. The Allscripts App Expo will also be on display in the Allscripts booth at ViVE (#450) at the annual Health Information Management Systems Society (HIMSS) conference March 15-17 in Orlando, FL in booth 1279. You can visit the new site at https://expo.allscripts.com and search by keyword, Allscripts products or categories.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...